Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats
- 1 July 1994
- journal article
- Published by Elsevier in Kidney International
- Vol. 46 (1) , 237-244
- https://doi.org/10.1038/ki.1994.265
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 36 references indexed in Scilit:
- Metabolic Clearance Rate of Arginine Vasopressin in Patients With CirrhosiHepatology, 1992
- Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and PregnancyNew England Journal of Medicine, 1988
- Chronic Blockade of Vasopressin Receptors in RatsJournal of Cardiovascular Pharmacology, 1986
- Discovery and Therapeutic Utility of Vasopressin Antagonists in RatsJournal of Cardiovascular Pharmacology, 1986
- Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patientsKidney International, 1983
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- Potential Role of Increased Sympathetic Activity in Impaired Sodium and Water Excretion in CirrhosisNew England Journal of Medicine, 1982
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascitesDigestive Diseases and Sciences, 1976
- [4-Phenylalanine]oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressinJournal of Medicinal Chemistry, 1975
- 4-Leucine-Oxytocin: Natriuretic, Diuretic, and Antivasopressin PolypeptideScience, 1968